Journal of
eISSN: 2376-0060
Submit manuscript...
Editorial Volume 9 Issue 2
Devastating effect of COVID-19 on tuberculosis management and care
Attapon Cheepsattayakorn,1,2 
Verify Captcha
Regret for the inconvenience: we are taking measures to prevent fraudulent form submissions by extractors and page crawlers. Please type the correct Captcha word to see email ID.
Ruangrong Cheepsattayakorn,3 Porntep Siriwanarangsun1
Verify Captcha
Regret for the inconvenience: we are taking measures to prevent fraudulent form submissions by extractors and page crawlers. Please type the correct Captcha word to see email ID.
1Faculty of Medicine, Western University, Thailand
210th Zonal Tuberculosis and Chest Disease Center, Thailand
3Department of Pathology, Faculty of Medicine, Chiang Mai University, Thailand
Correspondence: Attapon Cheepsattayakorn, 10th Zonal Tuberculosis and Chest Disease Center, 143 Sridornchai Road Changklan Muang Chiang Mai 50100 Thailand
Received: April 25, 2022 | Published: April 28, 2022
Citation: Cheepsattayakorn A, Cheepsattayakorn R, Siriwanarangsun P. Devastating effect of COVID-19 on tuberculosis management and care. J Lung Pulm Respir Res. 2022;9(2):36. DOI: 10.15406/jlprr.2022.09.00275
Editorial
The World Health Organization (WHO) Global Tuberculosis Report 2021 revealed worsening case notification and increased tuberculosis mortality due to pandemic-associated-service disruptions. As of December 31, 2021, about 8% and 76% of the people in low-income and high-income countries received at least one dose of COVID-19 vaccine, respectively. Approximately, 18% decrease of the estimated tuberculosis cases from 2019, particularly China, India, Indonesia, and the Philippines with healthcare service disruptions and major COVID-19 outbreak was demonstrated. Negative COVID-19-pandemic-associated effects included 15% decrease in number of drug-resistant-tuberculosis cases, 21% reduction in number of tuberculosis-preventive-treatment cases, and around 1.5 million tuberculosis death worldwide in 2020, contributing to off-tracking of the United Nations (UN) high-level meeting on 2022-tuberculosis-target establishment. By driving and ongoing COVID-19 surges in low- and middle-income countries, decrease in tuberculosis incidence dramatically have slowed.1 By failure in targeting the Sustainable Development Goals (SDG)’s tuberculosis mortality in 2030 would lead to vast economic and health losses.2
In conclusion, tuberculosis-field-working people should support the WHO plans and the Group of 20 Rome leaders’ declaration of both COVID-19 (70% of the world populations vaccinated by mid-2022) and tuberculosis. Tuberculosis programs should learn the real-time COVID-19 dashboards that are widely available.
Acknowledgments
None.
Conflicts of interest
None.
References
- World Health Organization. Global tuberculosis report 2021.
- Silva S, Arinaminpathy N, Atun R, et al. Economic impact of tuberculosis mortality in 120 countries and the cost of not achieving the Sustainable Development Goals tuberculosis targets : a full-income analysis. Lancet Glob Health. 2021; 9(10): e1372-e1379.
©2022 Cheepsattayakorn, et al. This is an open access article distributed under the terms of the, which permits unrestricted use, distribution, and build upon your work non-commercially.
Citations
November is Lung Cancer Awareness Month, a vital opportunity for us to raise awareness about the dangers of lung cancer. Let’s unite to educate ourselves and others, and inspire proactive steps toward lung health. This year the motto of this event is “Stronger Together: United for Lung Cancer Awareness”. So for this occasion, the Journal of Lung, Pulmonary & Respiratory Research invites articles that emphasize the significance of lung protection. All the submissions received in the month of November will be offered with 40% discount on publication.